Hematology in Focus sessions Saturday June 18

HEMATOLOGY-IN-FOCUS SESSION

09.30 - 10.15 hours, Auditorium

TOWARDS A NEW BIOLOGICAL PROGNOSTIC INDEX IN NON-HODGKIN'S LYMPHOMA
Chair: D. de Jong (The Netherlands Cancer Institute, Amsterdam,
The Netherlands)

• PREDICTING PROGNOSIS BY GENE EXPRESSION PROFILING
  R. Gascoyne (British Columbia Cancer Agency, Vancouver, Canada)
• INTRODUCTION OF A NEW INTERNATIONAL PROGNOSTIC INDEX (IPI)
  G. Salles (Centre Hospitalier Lyon-Sud, Lyon, France)

HEMATOLOGY-IN-FOCUS SESSION

09.30 - 10.15 hours, Forum

NPM1 IN ACUTE MYELOID LEUKEMIA
Chair: I. Touw (Erasmus Medical Center, Rotterdam, The Netherlands)

• NPM1 IN CANCER PATHOGENESIS
  P.P. Pandolfi (Memorial Sloan Kettering Cancer Center, New York, USA)
• BIOLOGICAL AND CLINICAL IMPLICATIONS OF NPM1 MUTATIONS
  B. Falini (Institute of Hematology, Perugia, Italy)

HEMATOLOGY-IN-FOCUS SESSION

09.30 - 10.15 hours, Room X

ACTIVATION OF COAGULATION – NEW INSIGHTS
Chair: D. Lane (Imperial College London, London, United Kingdom)

• THROMBIN - DIRECTOR OR SLAVE
  D. Lane (Imperial College London, London, United Kingdom)
• MEMBRANE MICROPARTICLES IN THE INITIATION AND PROPAGATION OF COAGULATION AND INTERCELLULAR COMMUNICATION
  J.M. Freyssinet (Institute of Hematology and Immunology, Strasbourg, France)

HEMATOLOGY-IN-FOCUS SESSION

09.30 - 10.15 hours, Room Y

IMMUNE RECONSTITUTION AFTER ALLO-HSC TRANSPLANTATION
Chair: A. Nagler (Sheba Medical Center, Tel-Hashomer, Israel)

• THYMIC RECONSTITUTION
  C. Blackburn (Institute for Stem Cell Research, Edinburgh, United Kingdom)
• INTERLEUKIN-7-MEDIATED IMMUNE RECONSTITUTION
  C.L. Mackall (National Cancer Institute, Bethesda, USA)
  

HEMATOLOGY-IN-FOCUS SESSION

09.30 - 10.15 hours, Room A

NOTCH1 SIGNALLING PATHWAY IN HEMATOLOGICAL MALIGNANCIES
Chair: J. Cools (University of Leuven, Leuven, Belgium)

• MOLECULAR MECHANISMS OF NOTCH ACTIVATION
  G. Weinmaster (UCLA School of Medicine, Los Angeles, USA)
• ACTIVATING NOTCH1 MUTATIONS IN HEMATOLOGICAL MALIGNANCIES
  J.C. Aster (Brigham and Women's Hospital, Boston, USA)
  

HEMATOLOGY-IN-FOCUS SESSION

09.30 - 10.15 hours, Room B

ROLE OF GATA-1 IN HEMATOPOIESIS
Chair: A. Migliaccio (Istituto Superiore Sanità, Rome, Italy)

• GATA-1 FORMS DISTINCT ACTIVATING AND REPRESSIVE COMPLEXES WITH DIFFERENT ROLES IN ERYTHROID DIFFERENTIATION
  J. Strouboulis (Erasmus Medical Center, Rotterdam, The Netherlands)
• GATA-1 IN NORMAL AND MALIGNANT HEMATOPOIESIS
  A. Migliaccio (Istituto Superiore Sanità, Rome, Italy)